Cargando…

Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation

In addition to their applicability as biopesticides, Bacillus thuringiensis (Bt) Cry1Ac spore-crystals are being researched in the immunology field for their potential as adjuvants in mucosal and parenteral immunizations. We aimed to investigate the hematotoxicity and genotoxicity of Bt spore-crysta...

Descripción completa

Detalles Bibliográficos
Autores principales: Mezzomo, Bélin Poletto, Miranda-Vilela, Ana Luisa, Grisolia, Cesar Koppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690131/
https://www.ncbi.nlm.nih.gov/pubmed/26690217
http://dx.doi.org/10.3390/toxins7124881
_version_ 1782406961411653632
author Mezzomo, Bélin Poletto
Miranda-Vilela, Ana Luisa
Grisolia, Cesar Koppe
author_facet Mezzomo, Bélin Poletto
Miranda-Vilela, Ana Luisa
Grisolia, Cesar Koppe
author_sort Mezzomo, Bélin Poletto
collection PubMed
description In addition to their applicability as biopesticides, Bacillus thuringiensis (Bt) Cry1Ac spore-crystals are being researched in the immunology field for their potential as adjuvants in mucosal and parenteral immunizations. We aimed to investigate the hematotoxicity and genotoxicity of Bt spore-crystals genetically modified to express Cry1Ac individually, administered orally (p.o.) or with a single intraperitoneal (i.p.) injection 24 h before euthanasia, to simulate the routes of mucosal and parenteral immunizations in Swiss mice. Blood samples were used to perform hemogram, and bone marrow was used for the micronucleus test. Cry1Ac presented cytotoxic effects on erythroid lineage in both routes, being more severe in the i.p. route, which also showed genotoxic effects. The greater severity noted in this route, mainly at 6.75 mg/kg, as well as the intermediate effects at 13.5 mg/kg, and the very low hematotoxicity at 27 mg/kg, suggested a possible inverse agonism. The higher immunogenicity for the p.o. route, particularly at 27 mg/kg, suggested that at this dose, Cry 1Ac could potentially be used as a mucosal adjuvant (but not in parenteral immunizations, due to the genotoxic effects observed). This potential should be investigated further, including making an evaluation of the proposed inverse agonism and carrying out cytokine profiling.
format Online
Article
Text
id pubmed-4690131
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-46901312015-12-30 Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation Mezzomo, Bélin Poletto Miranda-Vilela, Ana Luisa Grisolia, Cesar Koppe Toxins (Basel) Article In addition to their applicability as biopesticides, Bacillus thuringiensis (Bt) Cry1Ac spore-crystals are being researched in the immunology field for their potential as adjuvants in mucosal and parenteral immunizations. We aimed to investigate the hematotoxicity and genotoxicity of Bt spore-crystals genetically modified to express Cry1Ac individually, administered orally (p.o.) or with a single intraperitoneal (i.p.) injection 24 h before euthanasia, to simulate the routes of mucosal and parenteral immunizations in Swiss mice. Blood samples were used to perform hemogram, and bone marrow was used for the micronucleus test. Cry1Ac presented cytotoxic effects on erythroid lineage in both routes, being more severe in the i.p. route, which also showed genotoxic effects. The greater severity noted in this route, mainly at 6.75 mg/kg, as well as the intermediate effects at 13.5 mg/kg, and the very low hematotoxicity at 27 mg/kg, suggested a possible inverse agonism. The higher immunogenicity for the p.o. route, particularly at 27 mg/kg, suggested that at this dose, Cry 1Ac could potentially be used as a mucosal adjuvant (but not in parenteral immunizations, due to the genotoxic effects observed). This potential should be investigated further, including making an evaluation of the proposed inverse agonism and carrying out cytokine profiling. MDPI 2015-12-09 /pmc/articles/PMC4690131/ /pubmed/26690217 http://dx.doi.org/10.3390/toxins7124881 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mezzomo, Bélin Poletto
Miranda-Vilela, Ana Luisa
Grisolia, Cesar Koppe
Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation
title Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation
title_full Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation
title_fullStr Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation
title_full_unstemmed Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation
title_short Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation
title_sort toxicological evaluation of a potential immunosensitizer for use as a mucosal adjuvant—bacillus thuringiensis cry1ac spore-crystals: a possible inverse agonist that deserves further investigation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690131/
https://www.ncbi.nlm.nih.gov/pubmed/26690217
http://dx.doi.org/10.3390/toxins7124881
work_keys_str_mv AT mezzomobelinpoletto toxicologicalevaluationofapotentialimmunosensitizerforuseasamucosaladjuvantbacillusthuringiensiscry1acsporecrystalsapossibleinverseagonistthatdeservesfurtherinvestigation
AT mirandavilelaanaluisa toxicologicalevaluationofapotentialimmunosensitizerforuseasamucosaladjuvantbacillusthuringiensiscry1acsporecrystalsapossibleinverseagonistthatdeservesfurtherinvestigation
AT grisoliacesarkoppe toxicologicalevaluationofapotentialimmunosensitizerforuseasamucosaladjuvantbacillusthuringiensiscry1acsporecrystalsapossibleinverseagonistthatdeservesfurtherinvestigation